Irbesartán Sandoz

Irbesartan, the active ingredient in Irbesartán Sandoz, is a Angiotensin II receptor blocker (ARB) presented as an oral tablet for oral use. It treats hypertension and diabetic nephropathy in adult patients.

GNH USA supplies Irbesartán Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Irbesartan is an ARB that acts on the renin‑angiotensin‑aldosterone system to control blood pressure and protect the kidneys. - Hypertension: lowers elevated blood pressure and reduces cardiovascular risk. - Diabetic nephropathy: slows the progression of kidney damage in patients with type 2 diabetes. - Proteinuria: decreases urinary protein excretion, contributing to renal protection.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially after standing. - Headache: mild to moderate pain in the head region. - Fatigue: feeling unusually tired or weak. - Nausea: upset stomach with possible vomiting. - Abdominal pain: discomfort in the stomach area. - Cough: occasional dry throat irritation.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or throat requiring immediate medical attention. - Hyperkalaemia: elevated blood potassium that can affect heart rhythm. - Acute renal impairment: sudden decline in kidney function. - Severe hypotension: markedly low blood pressure causing faintness. - Hepatic injury: abnormal liver enzymes or jaundice. - Neutropenia: low white‑blood‑cell count increasing infection risk.

Before initiating therapy, clinicians should consider several safety measures. - Blood pressure monitoring: ensure adequate control and avoid excessive drops. - Renal function assessment: check serum creatinine and eGFR regularly. - Serum potassium checks: monitor for hyperkalaemia, especially with concomitant potassium‑sparing agents. - Pregnancy avoidance: contraindicated in pregnancy due to fetal toxicity risk. - Elderly caution: start at lower doses and titrate slowly. - Store at below 25°C: keep in the original pack, protect from moisture.

Irbesartan may interact with several medicines, requiring attention to avoid adverse outcomes. Major Interactions (Avoid): - Aliskiren (in diabetes): combined use can increase renal dysfunction and hyperkalaemia. - ACE inhibitors or other ARBs: concurrent use raises risk of hypotension and potassium excess. - Potassium‑sparing diuretics: may cause dangerous hyperkalaemia. - NSAIDs (e.g., ibuprofen): can impair renal function and blunt antihypertensive effect. Moderate Interactions (Monitor Closely): - Thiazide diuretics: additive blood‑pressure lowering effect, monitor for hypotension. - Lithium: may increase lithium concentrations, watch for signs of toxicity. - CYP2C9 inhibitors (e.g., fluconazole): can raise irbesartan plasma levels, consider dose adjustment.